Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Biopsy breast, Breast cancer, Mammogram
Clinical narrative: she cannot lift over 9 pounds.; diagnosed with left breast cancer; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient received BNT162b2 (BNT162B2), on 25Sep2021 as dose 2, single (Lot number: FF8839, Expiration Date: Dec2021) at the age of 43 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Dense breast tissue" (unspecified if ongoing), notes: Been followed by a breast specialist for the past 1.5 years  . The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose: 1, Batch/lot number: FC3182, Expiration Date: 02Oct2021, Dosage text: Unknown dosage shot left arm), administration date: 28Aug2021, when the patient was 43-year-old, for COVID-19 immunization. The following information was reported: BREAST CANCER (medically significant) with onset 01Apr2022, outcome "unknown", described as "diagnosed with left breast cancer"; ASTHENIA (non-serious), outcome "unknown", described as "she cannot lift over 9 pounds.". The patient underwent the following laboratory tests and procedures: Biopsy breast: (unspecified date) Negative, notes: Stated that she has to get a mammogram every six months and was previously biopsied and both were negative; (Mar2022) Positive, notes: Stated that at the end on March she had a biopsy and came back positive for early stage breast cancer; (Apr2022) Positive, notes: Stated that she got a mammogram and biopsy since vaccination and both came back positive for carcinoma in Apr2022; Mammogram: (unspecified date) Negative, notes: Stated that she has to get a mammogram every six months and was previously biopsied and both were negative; (Feb2022) Positive, notes: Stated that she had a mammogram at the end of Feb2022. Stated that at the end on March she had a biopsy and came back positive for early stage breast cancer; (Apr2022) Positive, notes: Stated that she got a mammogram and biopsy since vaccination and both came back positive for carcinoma in Apr2022. Therapeutic measures were taken as a result of breast cancer.  Additional information: The patient was diagnosed with left breast cancer on 01Apr2022. She did not know if this was a trigger. She got the Pfizer BioNTech Covid 19 vaccine in Aug2021 and the second dose in Sep2021. She had been followed by a breast specialist for the past 1.5 years because she had dense breast tissue. She had to get a mammogram every six months and was previously biopsied and both were negative. She got a mammogram and biopsy since vaccination and both came back positive for carcinoma in Apr2022. She had a mammogram at the end of Feb2022. At the end of March, she had a biopsy and came back positive for early stage breast cancer. It was pretty quick between the time of vaccination and her diagnosis. She got a double mastectomy on 11May2022. She was on work leave for one month and cleared to go back one month later. They took all of the breast tissue and that she could not lift over 9 pounds. She had other reconstruction pending.